跳至主要内容
临床试验/EUCTR2007-002940-86-BE
EUCTR2007-002940-86-BE进行中(未招募)不适用

Sepsis, Endothelial function, and Lipids in critically ill patients with Liver Failure (SELLIFA). Nutritional sub-study : Randomized controlled trial comparing the tolerance on lipid metabolism and safety of isocaloric parenteral nutrition with enteral nutrition. - SELLIFA nutritional trial

Cliniques Universitaires Saint-Luc – Université catholique de Louvain0 个研究点开始时间: 2007年7月26日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - All consecutive patients with a diagnosis of chronic liver failure ;
  • - Adult patient aged 18 years or above, and less than 85 ;
  • - Admission to the ICU for an expected period of > 24 hours;
  • - Planned total nutritional support;
  • - Informed consent of the patient or nearest relative.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Absolute contra-indications to enteral nutrition : total mechanical ileus, persistent vomiting, high output fistulas, uncertain gastrointestinal anastomosis ;
  • - Absolute contra-indications to parenteral nutrition : severe hypertriglyceridemia more than 6 mmol/l (545 mg/dL), severe diabetic ketoacidosis ;
  • - Age less than 18 years and more than 85 ;
  • - Pregnancy, including HELLP syndrome ;
  • - Active malignancy with metastases (localised hepatocellular carcinoma is not an exclusion criteria);
  • - Systemic chemotherapy in the last 4 weeks (trans-arterial chemo-embolisation for localised hepatocellular carcinoma is not an exclusion criteria) ;
  • - Acquired immunodeficiency syndrome and antiretroviral therapy

研究者

发起方
Cliniques Universitaires Saint-Luc – Université catholique de Louvain

相似试验